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Malaria is a parasitic disease that affects red blood 
cells. In West Africa, species of the protozoa 
(Plasmodium) are known to cause malaria – P. 
 falciparum, P. vivax, P. malariae and P. ovale. Of 
these, P. falciparum is the commonest and most 
1dangerous.  The parasite is transmitted in by the 
1,female mosquito of the Anopheles genus.
Up to 2 billion people are affected by malaria 
worldwide. About 300-500 million cases are 
reported annually with 2-3 million deaths per year. 
About 90% of these occur in sub-Saharan Africa 
most of who are pregnant women and children under 
4
5 years of age.  An estimated 30 million women 
living in malaria endemic areas get pregnant each 
year. For these women, malaria is a threat both to 
themselves and to their babies with up to 200,000 
newborn deaths each year attributed to malaria in 
5
pregnancy.  The exact burden of the disease in 
Nigeria is difficult to ascertain for many reasons 
including poor record keeping.
Malaria infection during pregnancy is a major 
public health problem in tropical and subtropical 
regions of the world. Malaria and pregnancy are 
mutually synergistic aggravating conditions. The 
physiological changes that occur in pregnancy and 
the pathological effects of malaria have a synergistic 
effect on the course of the illness. Malaria in 
pregnancy tends to be more atypical and more 
,  Adeadly. ddit ionally,  some anti-malarial  
medications are contraindicated in pregnancy and 
3
may cause adverse effects.  All these make the 
management of malaria in pregnancy more difficult.
Even though direct maternal mortality from malaria 
is less common in areas of stable transmission, P. 
falciparum infection is estimated to cause up to 
10,000 maternal deaths annually as well as 8-14 % 
of all low birth weight babies and 3-8 % of all infant 
deaths annually.
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ABSTRACT
Context: Malaria is a major public health problem in Nigeria. Pregnant women are particularly susceptible because 
of their reduced natural immunity and the presence of a unique form of the disease – placental malaria. Peripheral 
parasitaemia may be a guide to the presence or absence of placental malaria with its attendant sequelae.
Objectives: The goal of the study was to determine the prevalence of malaria parasitaemia in the Jos University 
Teaching Hospital and the socio-demographic risk factors for malaria parasitaemia.
Methodology: A descriptive cross sectional study was carried out at the antenatal clinic of Jos University Teaching 
st thHospital from 1  August to 30  September 2008. A structured interviewer-administered questionnaire was used to 
collect information about socio-demographic characteristics and blood samples obtained for malaria parasitaemia, 
blood group, haemoglobin solubility and HIV test. All the information obtained was analyzed using Epi-info 3.5.1, 
Atlanta, USA.
Results: The prevalence of malaria parasitaemia at booking antenatal visit in JUTH was 39.7%. The presence of 
sickle cell trait, use of insecticide treated nets, and those aged less than 20 years were protected against malaria 
parasitaemia. HIV seropositivity, primiparity and those with anaemia were more likely to have parasitaemia. Blood 
group, previous history of fever and the use of anti-malarial drugs did not have any association with malaria 
parasitaemia.
Conclusion: The prevalence of malaria parasitaemia in pregnancy is still high in spite of the availability of evidence-
based and cost-effective interventions to prevent malaria in pregnancy. 
INTRODUCTION
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Placental histology is considered the gold standard 
for the diagnosis of malaria in pregnancy especially 
,for epidemiological studies.  However, from a 
clinical perspective, there is still a role for peripheral 
,blood smears.
The pathophysiology of malaria in pregnancy is 
largely due to the alteration in immunity and the 
presence of a new organ (the placenta) in 
1
pregnancy.  Cell-mediated immunity is suppressed 
during pregnancy and this is thought to be 
responsible for the increased susceptibility of 
,
pregnant women to malaria.  However, this does not 
explain the diminished susceptibility to malaria 
observed in multigravid women compared to 
primigravidae. The increased risk of malaria 
amongst primigravidae is explained by the presence 
1of placental malaria.  
Placental sequestration of P. falciparum results in 
the accumulation of parasitized red blood cells in the 
placental intervillous space, inflammatory cell 
infiltration, and the release of mediators of 
8inflammation.  These cause pathologic changes in 
the placental bed that impairs feto-maternal 
exchanges that result in adverse pregnancy 
outcomes including spontaneous abortion, low birth 
weight, preterm delivery, intrauterine growth 
restriction, fetal anaemia, congenital malaria and 
8,,, 
perinatal mortality. Maternal deaths may result 
either directly from severe malaria or indirectly 
7
from malaria-related anaemia.  
In areas of stable transmission, acquired immunity 
3
is high.  Infection with P. falciparum may not result 
7in fever or other clinical symptoms  and incidental 
3peripheral parasitaemia is commonly seen.  The 
proportion of parasitized red blood cells is usually 
higher in the placenta than in the peripheral blood 
and placental infection may be detected in the 
absence of peripheral blood parasitaemia and may 
,even persist after anti-malarial treatment.  The 
principal impact of malaria in these areas is malaria-
7related anaemia and placental parasitaemia.  
Heavy placental parasitaemia and maternal anaemia 
may result in less nutritional support for the fetus 
leading to spontaneous abortion, still birth, 
3
prematurity and increased perinatal mortality.  
These problems are seen more in primigravidae. 
The occurrence of peripheral blood parasitaemia at 
the beginning, and at the end of pregnancy has been 
shown to be significantly related to placental 
infection whereas parasitaemia in the middle of 
pregnancy was not. Although maternal peripheral 
blood parasitaemia towards the end of pregnancy 
predisposes the woman to placental malaria, the risk 
of placental infection is greater if  peripheral 
parasitaemia occurred at the beginning of 
4pregnancy.  This suggests that peripheral blood 
parasitaemia at the beginning of pregnancy may 
persist within the placenta throughout pregnancy 
and may cause more serious complications for the 
fetus / newborn than infection acquired later in 
pregnancy.
Based on evidence, the World Health Organisation 
recommends a three-pronged approach to the 
prevention and management of malaria during 
pregnancy: sleeping under insecticide treated nets, 
intermittent preventive treatment with an anti-
malarial drug (currently sulphadoxine and 
pyrimethamine) and effective case management of 
7,13,malaria illness in pregnancy.  
This study was therefore aimed at determining the 
prevalence of malaria parasitaemia amongst 
pregnant women, and the associated socio-
demographic risk factors attending antenatal clinic 
at the Jos University Teaching Hospital, Jos.
METHODOLOGY
The study was carried out amongst pregnant women 
attending the booking visit at the antenatal clinic of 
the Jos University teaching Hospital, Jos, Plateau 
state in North Central Nigeria.
Study Design
This was a cross-sectional descriptive study.
Sample size
The minimum sample size was determined using the 
Fischer's formula
 2
n = (Z) (1-P)(P)
2
              d 
Where:
n = minimum sample size
Z = 95% confidence = interval (1.96)
P = prevalence of peripheral malaria parasitaemia 
23
in Nigerian pregnant women = 12% 
d = absolute precision at 95% confidence interval = 
0.05
2 n = (1.96 )  (1- 0.12) (0.12)
2                        (0.05)
 n = 162
In order to enhance the power of interpretation, 200 
pregnant women will be studied
Data Collection and Analysis
This study was carried out at the antenatal clinic of 
the Jos University Teaching Hospital between 
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August and September 2008. After appropriate 
counseling and obtaining informed consent, 200 
consecutive pregnant women were enrolled into the 
study at the booking visit.  Subjects enrolled in the 
study were interviewed with the aid of an 
investigator administered pre-structured 
questionnaire to obtain the socio-demographic and 
medical information. Blood samples were then 
obtained and screened for malaria by thin and thick 
smears using Giemsa staining. The packed cell 
volume, human immunodeficiency virus (HIV) 
screening, haemoglobin solubility and blood group 
were also determined from the obtained blood.  All 
information obtained were analyzed using Epi-info 
version 3.5.1. 
RESULTS
Two hundred (200) women were recruited into the 
study. However, one of the subjects was later 
discovered not to be pregnant and was subsequently 
excluded from the study (attrition rate 0.5%). Of the 
199 subjects, 79 had malaria parasites in peripheral 
blood smears. Thus, the prevalence of malaria 
parasitaemia in the study was 39.7%.
Table 1 is a descriptive statistics of the study 
population. The age distribution of the study 
population ranged from 16 to 42 years with a mean 
of 27.3 years (standard deviation 5.586). There were 
107 (53.8%) Christians and 92 (46.2%) Muslims 
involved in the study. Most of the women (197 – 
99.0%) were married, 1 (0.5%) was single and 1 
(0.5%) was divorced. Twelve (6.0%) of the women 
did not have any form of education, 7 (3.5%) had 
Arabic education while 88 (44.2%) had formal 
western education up to secondary school level. 
Forty-eight (24.1%) subjects identified themselves 
as housewives, 7 (3.5%) were unemployed, 32 
(16.1%) were students and others (12.1%) included 
nurses, hairdressers, accountants, caterers and a 
youth corps member.
The gestational age of the study population at the 
time of the study ranged from 7 to 38 weeks with a 
mean of 22.48 weeks (standard deviation, SD; 7.02). 
The mean parity of the subjects was 1.55 (SD;1.86). 
There were 103 (51.8%) women whose blood group 
was O, 51 (25.6%) blood group B,  31 (15.6%) 
blood group A and 14 (7.0%) had blood group AB. 
Fifty-three (26.6%) of the study population had the 
sickle cell trait. Only 44 (22.1%) of the study 
population used insecticide treated nets.
The packed cell volume of the study population 
ranged from 23% to 41% with a mean of 31.98% 
(SD;  3.19). Thirty-two (16.1%) had packed cell 
volume less than 30% which was the definition of 
anaemia in the study. Fifty-one (25.6%) of the 
subjects had a history of fever within the last 4 
weeks prior to the study.
Table 2 shows the relationship between the presence 
of malaria parasitaemia and various parameters. The 
presence of anaemia (p-value 0.0040), sickle cell 
trait (0.0001) and HIV seropositivity (p-value 
0.0001) were significantly associated with malaria 
parasitaemia.
Table 3 shows the logistic regression statistics to 
account for confounding variables. The results show 
that the use of insecticide treated net (OR 0.3214), 
sickle cell trait (OR 0.227) and age less than 20 years 
(OR 0.2745) were protective against malaria 
parasitaemia. HIV positive subjects (OR 13.2091), 
primigravidae (OR 2.2642) and subjects with 
anaemia (OR 3.8155) were more likely to have 
malaria parasitaemia.
Table 1: Characteristics of study population
Frequency (N =199)                 %
Age     
15 –
 
19                                                                  15                                  7.5
20 –
 
24                                         
                         
48                    24.2                  
25 –
 
29                                                                  58 29.1
30 –
 
34                                                       
           
53      26.6
35 –
 
39                                                                  23 11.6
40 -
 
44                                                                    2 1.0
Religion:  Christian                                                       107 53.8
       Muslim                                                         92 46.2
Marital status 
Married                                                             197    99.0
Single                                                                    1  0.5
Divorced                                                               1                                       0.5
Occupation
 
Business women                                                        21                                    10.6
Civil servant                  
                                            
15                                      7.5
Housewife                                                                 48 24.1
Student                                            
                         
32                      16.1  
Tailors                                                     42     21.1
Teacher                                                         10                                       5.0
Unemployed                                                              7                                       3.5
Others                                                                      24 12.1
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Educational status 
None                                                                         12 6.0 
Primary                                                                    29 14.6
Secondary                                                               88  44.2
Tertiary                                                                   63 31.7 
Arabic                                                                       7  3.5
Gestational age at booking 
First trimester                                                          25 12.6 
Second trimester                                                    113  56.7
Third trimester                                                         61 30.7
Parity:  0                                                                             77  38.7 
  1                                                                             41 20.6 
  2                                                                             33  16.6 
  3                                                                             24 12.1 
  4                                                                               9 4.5 
  =5                                                                           15                                          
7.5 
Blood group 
A                                                                                      31 15.6
B                                                                                      14  7.0
AB                                                                                   51 25.6
O                                                                                    103       51.8
Genotype 
AA                                                                                 146       73.4
AS                                                                                    50      25.1
SS                                                                               3              1.5
Table 2: Relationship between parasitaemia and 
various parameters
Yes                                                9 44                     
Parasitaemia           
Present      Absent               Total
Presence of anaemia
Yes                                                  20 12      
32
No                                                 59 108                    
167




= 8.2815      p-value = 0.0040
Anti-malarial use  
 
Yes                                 
               
33                45                     
78                                                                                       
No                                                46 75                    121
Total                                             79 120 199
÷2
 
= 0.3648    p-value = 0.5458
History of fever
Yes                                                25 26 51
No                                                54 94   
148
Total                                              79 120                
199
÷2 = 2.488    p-value = 0.1147
Sickle cell trait
53
No                                             70 76                    
146
Total                                            79 120   
199
÷2 = 15.5736    p-value = 0.0001
HIV screen
Positive                                        13     2
15
Negative                                      66 118         
184




= 14.9497   p-value = 0.0001
Use of insecticide treated net
 
Yes                                     12              32 44
No                                    67                88         
155
Total                                   79              
                     
120                        
199
     
÷2
 
= 3.6435   p-value 0.05663
Age less than 20 years
Yes                                 10                                     25
No                 69                                      95
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DISCUSSION
The prevalence rate of 39.7% for malaria 
parasitaemia amongst pregnant women in thus 
study was much higher than the rate of 12% in a 
study from south western Nigeria and 13% from 
Benin City. However, this is much less than 80% in a 
study from south eastern Nigeria. A Mozambican 
study reports a prevalence of 35.3%. The 
differences in prevalence rates reported in the 
various studies may be due to differences in the 
study population. It may also be accounted for by the 
time of the year the study was done as increased 
25
parasitaemia has been noted in the rainy season.
There was no association between a history of fever 
and malaria parasitaemia. This is not surprising as 
malarial infection in endemic areas like Nigeria may 
16not result in clinical symptoms.  There was no 
association between anti-malarial use and malarial 
parasitaemia. Several studies have shown that the 
use of sulphadoxine-pyrimethamine combination 
22,
decreased the prevalence of malarial parasitaemia . 
The lack of association in this study may be due to 
the study design. Some of the subjects may have 
taken the anti-malarial drug a short while before the 
study and this may not have had an effect on the 
presence of parasitaemia.
There was low usage (22.1%) of insecticide treated 
nets amongst pregnant women in the Jos University 
Teaching Hospital. A similar study from Jos showed 
that only 22.0% of antenatal women use insecticide 
27treated nets.  The reasons given for non-utilization 
from that study were:  non-availability of the nets 
and the cost of the nets. The use of insecticide 
treated nets was found to be associated with reduced 
parasitaemia in this study (OR 0.3214, p-value 
0.0120). This is not surprising as evidence supports 
the use of insecticide treated nets to prevent malaria 
9,
in pregnancy .
The prevalence of HIV seropositivity in the study 
(7.5%) though higher than the Nigerian national 
average (4.4%) , is close to the 8.2% from a previous 
investigation. This study shows that HIV positive 
subjects have an increased risk of malaria 
parasitaemia (OR 13.2091, p-value 0.0033). This is 
consistent with studies that have shown an 
,association between HIV and Malaria.
There was no association between blood group and 
parasitaemia. Even though blood group O has been 
found to be significantly associated with increased 
placental malarial infection in primigravidae and 
reduced risk of infection in multiparae, no studies 
have been identified that assess the relationship 
between ABO blood group and peripheral malarial 
parasitaemia.
Sickle cell trait was associated with a significantly 
reduced rate of malaria parasitaemia (OR 0.2270, p-
value 0.0006). It is known that the sickle cell trait is 
protective against malaria. This  study also shows 
that those less than 20 years are less likely to have 
malaria parasitaemia (OR o.2745, p-value 0.0136). 
A previous study had shown increased prevalence of 
malaria parasitaemia in this age group. The reason 
for the reduced prevalence in this study is unclear 
but may be that the younger age groups are more 
likely to be educated  about malaria preventive 
measures like intermittent preventive treatment and 
the use of insecticide treated nets. However, this will 
require further evaluation.
Women with anaemia were significantly more prone 
to have malaria parasitaemia (OR 3.8155, p-value 
÷2 = 2.1965   p-value = 0.1383
Parity           
0                                    35                                            42                  
77
Others                               44                                            78                             
122
Total                                 79                            120                          
199
÷2 = 1.7353   p -value = 0.1874
Religion             Christians                           43                                          64                     
107
Muslims                            36                                           56                              
92
Total                               79                                          120      
199
÷2  = 0.0231   p-value = 0.8792
_______________________________________________ _________________________
Table 3:  Logistic regression statistics showing various asso ciations with 
parasitaemia
Term                    Odds Ratio       95 %  C.I.       Coefficient         S.E.        Z -Statistics     
P-Value
Anaemia                 3.8155 1.5067   9.6623 1.3391         0.4741 2.8247        
0.0047
HIV screen   13.2091          2.3567  74.0358       2.5809         0.8794         2.9348       
0.0033
ITN    0.3214 0.1326    0.7793      -1.1349         0.4518 -2.5118
0.0121
ITN    0.3214 0.1326    0.7793      -1.1349         0.4518 -2.5118
0.0121
Age less than 20    0.2745
       
0.0983   0.7668
  
-1.2927
        
0.5241        -2.4667       
0.0136
Primipara              2.2642      1.0712    4.7858    0.8172        0.3819         2.1402        
0.0323
Sickle trait            0.2271
      
0.0968    0.5322
  
-1.4828       0.4348        -3.4105        
0.0006
CONSTANT * * * -0.3518       0.2455        -1.4332       
0.1518
32
Trop J Obstet Gynaecol, 29 (1), April 2012
0.0047). The association between malaria and 
anaemia in malaria endemic areas has been clearly 
16,
documented.   Accordingly, this was not A 
surprising finding. Primiparous women had an 
increased risk of malaria parasitaemia in the study 




The prevalence of malaria parasitaemia in Jos 
University Teaching Hospital is 39.7%. The 
presence of sickle cell trait, use of insecticide treated 
nets and those less than 20 years were protected 
against malaria parasitaemia. HIV seropositivity, 
primiparity and those with anaemia were more 
likely to have parasitaemia.
Even though the protective effect of using 
insecticide treated nets is well established, the use of 
such nets among pregnant women attending 
antenatal clinic in JUTH is very low. Efforts should 
be made to make insecticide treated nets more 
affordable and readily available. The use of 
insecticide treated nets amongst women in the 
reproductive age group should be promoted as a 
means of reducing the incidence of malaria in 
pregnancy and its attendant complications.
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